Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

repotrectinib MeSH Supplementary Concept Data 2025


MeSH Supplementary
repotrectinib
Unique ID
C000708510
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000708510
Entry Term(s)
(1Z)-6-Fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentaazatetracyclo(13.5.2.04,9.018,22)docosa-1,4,6,8,15,19,21-heptaen-14-one
1,15-Etheno-1H-pyrazolo(4,3-f)(1,4,8,10)benzoxatriazacyclotridecin-4(5H)-one, 11-fluoro-2,6,7,13-tetrahydro-7,13-dimethyl-, (14Z)-
Registry Numbers
08O3FQ4UNP
Heading Mapped to
*Pyrazoles
*Macrocyclic Compounds
Frequency
9
Note
ROS1-TRK-ALK inhibitor
Source
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 May 1;1144:122098.
Date of Entry
2020/07/08
Revision Date
2020/08/21
repotrectinib Preferred
(1Z)-6-Fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentaazatetracyclo(13.5.2.04,9.018,22)docosa-1,4,6,8,15,19,21-heptaen-14-one Broader
page delivered in 0.005s